Literature DB >> 26123416

Functional studies cast light on receptor states.

Frederick J Ehlert1.   

Abstract

Contemporary analysis of the functional responses of G-protein-coupled receptors (GPCRs) usually addresses drug-receptor interactions from the perspective of the average behavior of the receptor population. This behavior is characterized in terms of observed affinity and efficacy. Efficacy is a measure of how well a drug activates the receptor population and observed affinity a measure of how potently a drug occupies the receptor population. The latter is quantified in terms of the dissociation constant of the ligand-receptor complex. At a deeper level of analysis, drug-receptor interactions are described in terms of ligand affinity constants for active and inactive receptor states. Unlike observed affinity and efficacy, estimates of receptor state affinity constants are unperturbed by G proteins, guanine nucleotides, or other signaling proteins that interact with the receptor. Recent advances in the analysis of the functional responses of GPCRs have enabled the estimation of receptor state affinity constants. These constants provide a more fundamental measure of drug-receptor interactions and are useful in analyzing structure-activity relationships and in quantifying allosterism, biased signaling, and receptor-subtype selectivity.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  agonist bias; allosterism; functional studies; receptor state affinity constants; single-receptor behavior

Mesh:

Substances:

Year:  2015        PMID: 26123416      PMCID: PMC4562878          DOI: 10.1016/j.tips.2015.05.008

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  44 in total

1.  A simple method for estimation of agonist activity at receptor subtypes: comparison of native and cloned M3 muscarinic receptors in guinea pig ileum and transfected cells.

Authors:  F J Ehlert; M T Griffin; G W Sawyer; R Bailon
Journal:  J Pharmacol Exp Ther       Date:  1999-05       Impact factor: 4.030

2.  A modification of receptor theory.

Authors:  R P STEPHENSON
Journal:  Br J Pharmacol Chemother       Date:  1956-12

3.  Signaling through the muscarinic receptor-adenylate cyclase system of the heart is buffered against GTP over a range of concentrations.

Authors:  F J Ehlert; B E Rathbun
Journal:  Mol Pharmacol       Date:  1990-07       Impact factor: 4.436

Review 4.  Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors.

Authors:  D Colquhoun
Journal:  Br J Pharmacol       Date:  1998-11       Impact factor: 8.739

5.  Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.

Authors:  F J Ehlert
Journal:  Mol Pharmacol       Date:  1988-02       Impact factor: 4.436

6.  Operational models of pharmacological agonism.

Authors:  J W Black; P Leff
Journal:  Proc R Soc Lond B Biol Sci       Date:  1983-12-22

7.  The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor.

Authors:  F J Ehlert; M T Griffin; P F Glidden
Journal:  J Pharmacol Exp Ther       Date:  1996-12       Impact factor: 4.030

8.  The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2.

Authors:  M A Wall; D E Coleman; E Lee; J A Iñiguez-Lluhi; B A Posner; A G Gilman; S R Sprang
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

9.  Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.

Authors:  S Lazareno; N J Birdsall
Journal:  Mol Pharmacol       Date:  1995-08       Impact factor: 4.436

10.  Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis.

Authors:  D E Coleman; A M Berghuis; E Lee; M E Linder; A G Gilman; S R Sprang
Journal:  Science       Date:  1994-09-02       Impact factor: 47.728

View more
  9 in total

1.  Approaches to Assess Biased Signaling at the CB1R Receptor.

Authors:  Robert B Laprairie; Edward L Stahl; Laura M Bohn
Journal:  Methods Enzymol       Date:  2017-07-05       Impact factor: 1.600

2.  A method for the quantification of biased signalling at constitutively active receptors.

Authors:  David A Hall; Jesús Giraldo
Journal:  Br J Pharmacol       Date:  2018-04-25       Impact factor: 8.739

3.  Estimation of the receptor-state affinity constants of ligands in functional studies using wild type and constitutively active mutant receptors: Implications for estimation of agonist bias.

Authors:  Frederick J Ehlert; Richard S L Stein
Journal:  J Pharmacol Toxicol Methods       Date:  2016-10-07       Impact factor: 1.950

Review 4.  Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.

Authors:  David R Janero; Ganesh A Thakur
Journal:  Expert Opin Drug Discov       Date:  2016-10-21       Impact factor: 6.098

5.  Quantitative Measure of Receptor Agonist and Modulator Equi-Response and Equi-Occupancy Selectivity.

Authors:  Rumin Zhang; Michael Kavana
Journal:  Sci Rep       Date:  2016-04-27       Impact factor: 4.379

6.  A three-parameter two-state model of receptor function that incorporates affinity, efficacy, and signal amplification.

Authors:  Peter Buchwald
Journal:  Pharmacol Res Perspect       Date:  2017-04-27

7.  A Complementary Scale of Biased Agonism for Agonists with Differing Maximal Responses.

Authors:  Javier Burgueño; Marta Pujol; Xavier Monroy; David Roche; Maria Jose Varela; Manuel Merlos; Jesús Giraldo
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

Review 8.  Allosteric Modulation of Neurotransmitter Transporters as a Therapeutic Strategy.

Authors:  Marco Niello; Ralph Gradisch; Claus Juul Loland; Thomas Stockner; Harald H Sitte
Journal:  Trends Pharmacol Sci       Date:  2020-05-26       Impact factor: 14.819

Review 9.  A brief overview about the adipokine: Isthmin-1.

Authors:  Min Hu; Xin Zhang; Can Hu; Teng Teng; Qi-Zhu Tang
Journal:  Front Cardiovasc Med       Date:  2022-07-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.